Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA consolidated Locations section has been added listing Ohio, Texas, and Washington as study sites, replacing the prior state-specific location subsections, and the page revision label updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.5%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive study details appear to be changed.SummaryDifference0.1%

- Check48 days agoChange DetectedPublications section now indicates entries are automatically filled from PubMed, and the page revision is updated to v3.3.1.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the government funding lapse notice at the top of the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedThe two screenshots show only minor UI/layout updates with no changes to core study details (inclusion criteria, outcomes, enrollment, status, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a government operating status notice and updated version to v3.2.0; removed a previous specific disease term and downgraded to v3.1.0. The update emphasizes current operating status and versioning over the deleted term.SummaryDifference5%

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.